This week’s episode takes a look at ongoing research into the use of psychedelic compounds to help treat conditions ranging from depression to asthma.  The episode goes in depth into the changing stigma surrounding psychedelics and how a new pharmaceutical front of the “war on drugs” could be bringing the “war” to an end. This episode is based on an interview with a chemistry researcher at LSU, Ben Cummins, who gave many insights into how psychedelic applications could possibly change the world in the next decade.